Rentech Ltd company a biotech company, is expected to grow rapidly in the next three years and then have a level growth rate for the foreseeable future. The company expects free cash flows of $$372\mathrm{.}1$ million, $$541\mathrm{.}7$ million, and $$827\mathrm{.}0$ million over the next three years, and thereafter its cash flows will grow at a steady rate of $5$ percent per annum. The company has no non$-$operating assets $($NOA$).$ If the appropriate WACC is $9\mathrm{.}23$ percent, what is the enterprise value of this business?